Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years

F. Pasini, G. Verlato, E. Durante, G. De Manzoni, F. Valduga, S. Accordini, C. Pedrazzani, A. Terzi, G. Pelosi

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Among patients with non-small-cell lung cancer (NSCLC), those with pathological stage I have the best expectation of survival; however, survival is reduced to less than 50% in the long term. At present, it is unclear when patients can be reasonably defined as cured, and if they experience a higher incidence of malignant/nonmalignant diseases and a lower expectation of survival than the general population. A total of 134 stage I NSCLC patients, who had undergone resection at the Thoracic Surgery Unit of the General Hospital of Verona (north-eastern Italy) from October 1987 to December 1993, were still disease-free at 5 years. These subjects were further followed up, and morbidity and mortality rates were compared with those recorded in the general population of the same geographical area. The standardised incidence ratios (SIRs) for all malignancies and for lung cancer were higher than expected (2.39, 95% CI=1.6-3.5, P

Original languageEnglish
Pages (from-to)1666-1668
Number of pages3
JournalBritish Journal of Cancer
Volume88
Issue number11
DOIs
Publication statusPublished - Jun 2 2003

Fingerprint

Non-Small Cell Lung Carcinoma
Lung Diseases
Lung Neoplasms
Survival
Mortality
Incidence
General Hospitals
Italy
Population
Thoracic Surgery
Morbidity
Neoplasms

Keywords

  • Long-term survival
  • Non-small-cell lung cancer
  • Standardised imortality ratio
  • Standardised incidence ratio

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Cite this

Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years. / Pasini, F.; Verlato, G.; Durante, E.; De Manzoni, G.; Valduga, F.; Accordini, S.; Pedrazzani, C.; Terzi, A.; Pelosi, G.

In: British Journal of Cancer, Vol. 88, No. 11, 02.06.2003, p. 1666-1668.

Research output: Contribution to journalArticle

Pasini, F, Verlato, G, Durante, E, De Manzoni, G, Valduga, F, Accordini, S, Pedrazzani, C, Terzi, A & Pelosi, G 2003, 'Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years', British Journal of Cancer, vol. 88, no. 11, pp. 1666-1668. https://doi.org/10.1038/sj.bjc.6600991
Pasini, F. ; Verlato, G. ; Durante, E. ; De Manzoni, G. ; Valduga, F. ; Accordini, S. ; Pedrazzani, C. ; Terzi, A. ; Pelosi, G. / Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years. In: British Journal of Cancer. 2003 ; Vol. 88, No. 11. pp. 1666-1668.
@article{b39f1fa4b9824cb6a360bf07e6e00432,
title = "Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years",
abstract = "Among patients with non-small-cell lung cancer (NSCLC), those with pathological stage I have the best expectation of survival; however, survival is reduced to less than 50{\%} in the long term. At present, it is unclear when patients can be reasonably defined as cured, and if they experience a higher incidence of malignant/nonmalignant diseases and a lower expectation of survival than the general population. A total of 134 stage I NSCLC patients, who had undergone resection at the Thoracic Surgery Unit of the General Hospital of Verona (north-eastern Italy) from October 1987 to December 1993, were still disease-free at 5 years. These subjects were further followed up, and morbidity and mortality rates were compared with those recorded in the general population of the same geographical area. The standardised incidence ratios (SIRs) for all malignancies and for lung cancer were higher than expected (2.39, 95{\%} CI=1.6-3.5, P",
keywords = "Long-term survival, Non-small-cell lung cancer, Standardised imortality ratio, Standardised incidence ratio",
author = "F. Pasini and G. Verlato and E. Durante and {De Manzoni}, G. and F. Valduga and S. Accordini and C. Pedrazzani and A. Terzi and G. Pelosi",
year = "2003",
month = "6",
day = "2",
doi = "10.1038/sj.bjc.6600991",
language = "English",
volume = "88",
pages = "1666--1668",
journal = "British Journal of Cancer",
issn = "0007-0920",
publisher = "Nature Publishing Group",
number = "11",

}

TY - JOUR

T1 - Persistent excess mortality from lung cancer in patients with stage I non-small-cell lung cancer, disease-free after 5 years

AU - Pasini, F.

AU - Verlato, G.

AU - Durante, E.

AU - De Manzoni, G.

AU - Valduga, F.

AU - Accordini, S.

AU - Pedrazzani, C.

AU - Terzi, A.

AU - Pelosi, G.

PY - 2003/6/2

Y1 - 2003/6/2

N2 - Among patients with non-small-cell lung cancer (NSCLC), those with pathological stage I have the best expectation of survival; however, survival is reduced to less than 50% in the long term. At present, it is unclear when patients can be reasonably defined as cured, and if they experience a higher incidence of malignant/nonmalignant diseases and a lower expectation of survival than the general population. A total of 134 stage I NSCLC patients, who had undergone resection at the Thoracic Surgery Unit of the General Hospital of Verona (north-eastern Italy) from October 1987 to December 1993, were still disease-free at 5 years. These subjects were further followed up, and morbidity and mortality rates were compared with those recorded in the general population of the same geographical area. The standardised incidence ratios (SIRs) for all malignancies and for lung cancer were higher than expected (2.39, 95% CI=1.6-3.5, P

AB - Among patients with non-small-cell lung cancer (NSCLC), those with pathological stage I have the best expectation of survival; however, survival is reduced to less than 50% in the long term. At present, it is unclear when patients can be reasonably defined as cured, and if they experience a higher incidence of malignant/nonmalignant diseases and a lower expectation of survival than the general population. A total of 134 stage I NSCLC patients, who had undergone resection at the Thoracic Surgery Unit of the General Hospital of Verona (north-eastern Italy) from October 1987 to December 1993, were still disease-free at 5 years. These subjects were further followed up, and morbidity and mortality rates were compared with those recorded in the general population of the same geographical area. The standardised incidence ratios (SIRs) for all malignancies and for lung cancer were higher than expected (2.39, 95% CI=1.6-3.5, P

KW - Long-term survival

KW - Non-small-cell lung cancer

KW - Standardised imortality ratio

KW - Standardised incidence ratio

UR - http://www.scopus.com/inward/record.url?scp=0037591582&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037591582&partnerID=8YFLogxK

U2 - 10.1038/sj.bjc.6600991

DO - 10.1038/sj.bjc.6600991

M3 - Article

VL - 88

SP - 1666

EP - 1668

JO - British Journal of Cancer

JF - British Journal of Cancer

SN - 0007-0920

IS - 11

ER -